Brentuximab Vedotin Combined with Chemotherapy in Newly Diagnosed, Early-Stage, Unfavorable-Risk Hodgkin Lymphoma: Extended Follow-up with Evaluation of Baseline Metabolic Tumor Volume and PET2Robert Stuver,Laure Michaud,Carla Casulo,Ranjana H. Advani,Elizabeth L. Budde,Paul M. Barr,Connie Lee Batlevi,Philip C Caron,Louis S. Constine,Savita Dandapani,Pamela Drullinsky,Jonathan W. Friedberg,Clare Grieve,Audrey Hamilton,Paul A. Hamlin,Richard Hoppe,Steven M. Horwitz,Niloufer Khan,Matthew J. Matasar,Ariela NoyBlood（2022）引用 1|浏览21暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
